Hutchison Medipharma

17 articles about Hutchison Medipharma

• WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China

  9/12/2018

  WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate®) for metastatic colorectal cancer from the National Medical Products Administration of China

• Hutchison Medipharma To Receive $10 Million Milestone From Eli Lilly

  10/27/2015

• Janssen Pharmaceutical Ends Partnership With China's Hutchison Medipharma

  8/19/2015

• China's Hutchison Medipharma Receives $18 Million In Payments From Eli Lilly

  5/13/2015

• Hutchison Medipharma's Cancer Drug Meets Endpoint In Phase II Trial

  4/1/2015

• Hutchison Medipharma Starts Phase III Trial Of Cancer Drug

  12/18/2014

• Week in Review: Hutchison Medipharma Partners Cancer Drug With Eli Lilly and Company

  10/14/2013

• Hutchison Medipharma Out-Licenses Cancer Drug to Eli Lilly and Company for $86.5 Million

  10/11/2013

• Hutchison Medipharma Receives $6 Million Milestone From Janssen Pharmaceutical Inc.

  10/10/2013

• Hutchison Medipharma Starts Clinical Trial on Fourth Cancer Drug

  11/2/2012

• Hutchison Medipharma Releases Phase I Data on Two Cancer Molecules

  6/8/2012

• Hutchison Medipharma Starts Phase I Trial of Fourth Cancer Molecule

  2/22/2012

• The Week in Review: Hutchison Medipharma and AstraZeneca PLC Partner on Cancer Drug

  12/28/2011

• Hutchison Medipharma Starts Clinical Trial of Cancer Drug

  11/14/2011

• CEO of Hutchison Medipharma Quietly Steps Back

  10/18/2011

• Hutchison Medipharma Starts Clinical Trial of Second Cancer Drug

  2/1/2011

• Hutchison Medipharma Books $7.7 Million from SBCVC Fund

  12/22/2010